RF (radiofrequency) arrhythmia ablation proves safe in infants:
This article was originally published in Clinica
A US study has quashed concerns that using radiofrequency catheter ablation (RFCA) as a treatment for tachycardia may not be as effective and safe in infants as it is in older paediatric patients. Andrew Blaufox, of the Medical University of South Carolina in Charleston and his team found no statistical difference between infants and older patients in RFCA's effectiveness in treating arrhythmias, although the trend in success favoured the older patients, 90% versus 87.6% for infants, the team reports in Circulation (December 4).
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.